US Broker Ratings

uniQure N.V. (QURE) Stock Analysis: A Closer Look at Its 9.79% Potential Upside and Robust Pipeline

Investors eyeing the biotechnology sector may find uniQure N.V. (QURE), a leading player in the gene therapy space, an intriguing opportunity. With a market capitalization of $4.18 billion and its..

STAAR Surgical Company (STAA) Stock Analysis: Navigating the Healthcare Sector with a 186.83 Forward P/E

STAAR Surgical Company (NASDAQ: STAA) stands as a noteworthy entity in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.31 billion, this..

Delcath Systems, Inc. (DCTH) Stock Analysis: Major Upside Potential with a 150% Target Price Surge

For investors keen on tapping into the healthcare sector, Delcath Systems, Inc. (NASDAQ: DCTH) presents an intriguing opportunity. With a focus on innovative treatments for liver cancers, Delcath sits at..

Immunome, Inc. (IMNM) Stock Analysis: Unpacking a 50% Potential Upside in Biotech

Immunome, Inc. (NASDAQ: IMNM) is capturing the attention of investors in the healthcare sector with its promising biotech developments and the potential for significant stock appreciation. Based in Bothell, Washington,..

CeriBell, Inc. (CBLL) Stock Analysis: A 151% Potential Upside in the Healthcare Sector

CeriBell, Inc. (CBLL), a promising player in the healthcare sector, is capturing investor attention with its innovative approach to neurological care. The company, headquartered in Sunnyvale, California, operates within the..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A High-Stakes Biotech with 43% Upside Potential

Praxis Precision Medicines, Inc. (PRAX) is gaining attention in the biotechnology sector, particularly among investors with a keen interest in companies developing breakthrough therapies for central nervous system (CNS) disorders...

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Navigating the Biotech Waters with a 48.8% Revenue Boost

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) has been making waves in the biotechnology industry with its innovative approach to addressing chronic endocrine and neurological diseases. Headquartered in Chicago, Illinois, the..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a 20.5% Revenue Growth Amidst Market Challenges

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid sector, is capturing investor attention with its noteworthy 20.5% revenue growth, despite facing a complex market landscape. Headquartered in..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: A Potential 56.69% Upside in the Biotech Arena

Arcus Biosciences, Inc. (NASDAQ: RCUS) is making waves in the biotechnology sector with its promising portfolio of cancer therapies. As a clinical-stage biopharmaceutical company, Arcus is focused on developing and..

Syndax Pharmaceuticals, Inc. (SNDX) Investor Outlook: A Potential 186% Upside on Promising Cancer Therapies

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) stands out in the biotechnology sector with a compelling growth narrative, particularly for investors seeking exposure to innovative cancer treatments. With a market capitalization of..

Zymeworks Inc. (ZYME) Stock Analysis: Biotechnology Innovator with a 27.9% Potential Upside

Zymeworks Inc. (NASDAQ: ZYME), a burgeoning player in the biotechnology sector, has caught the attention of investors with its promising therapeutic platforms and partnerships. With a market capitalization of $1.45..

CareDx, Inc. (CDNA) Stock Analysis: Uncovering a Potential 50.89% Upside in the Diagnostics Sector

As the healthcare landscape continues to evolve, CareDx, Inc. (NASDAQ: CDNA) stands out within the diagnostics and research industry. With a market capitalization of $770.19 million, the company is carving..

InMode Ltd. (INMD) Stock Analysis: Exploring the 13% Potential Upside in Medical Device Innovator

In the rapidly evolving healthcare sector, InMode Ltd. (NASDAQ: INMD) stands out as a noteworthy player in the medical devices industry. Headquartered in Yokne’am, Israel, InMode has been making significant..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Unveiling a Potential 135% Upside in the Biotech Sector

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to developing small-molecule drugs targeting organ fibrosis. Headquartered..

Ardelyx, Inc. (ARDX) Stock Analysis: A 126% Potential Upside for Biotech Enthusiasts

Ardelyx, Inc. (NASDAQ: ARDX) is garnering attention in the biotechnology sector, with a notable potential upside of 126.82% based on current analyst ratings. This Waltham, Massachusetts-based company is focused on..

CureVac N.V. (CVAC) Stock Analysis: Riding the mRNA Wave Amidst Challenges

Investors eyeing the biotechnology sector are increasingly focusing on CureVac N.V. (NASDAQ: CVAC), a German biopharmaceutical company with a market cap of $1.21 billion. Known for its pioneering work in..

DoubleVerify Holdings, Inc. (DV) Stock Analysis: Potential Upside and Revenue Growth Drive Investor Interest

DoubleVerify Holdings, Inc. (NYSE: DV), a prominent player in the technology sector, offers a compelling opportunity for investors seeking exposure to digital media analytics. With a market capitalization of $1.86..

Diebold Nixdorf (DBD) Stock Analysis: Uncovering a 31.78% Potential Upside in the Tech Sector

Diebold Nixdorf Incorporated (NYSE: DBD), a stalwart in the technology sector, is catching the attention of investors with its significant potential upside of 31.78%. As a key player in the..

Cadence Design Systems, Inc. (CDNS) Stock Analysis: Unveiling a 10.79% Upside Potential

Cadence Design Systems, Inc. (NASDAQ: CDNS), a titan in the technology sector, is capturing the attention of investors with its software solutions for electronic design automation. With a market capitalization..

Paycom Software, Inc. (PAYC) Stock Analysis: Unveiling a 30% Potential Upside

Paycom Software, Inc. (NASDAQ: PAYC), a key player in the cloud-based human capital management (HCM) space, has captured the attention of investors with its robust business model and promising financial..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds